Medgenics (MDGN) Misses Q1 EPS by 8c

Medgenics (NYSE: MDGN) reported Q1 EPS of ($0.34), $0.08 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Medgenics (MDGN) click here.

You May Also Be Interested In

• RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
• DeFi Development Corp. reports SOL treasury growth of 11% since August